MONDELEZ INTERNATIONAL INC Common Stock vs Synopsys, Inc. — how do they compare? MONDELEZ INTERNATIONAL INC Common Stock trades at $60.36 (market cap $77.43B), while Synopsys, Inc. trades at $509.81 (market cap $95.39B). The key difference: Synopsys, Inc. is the larger of the two by market cap, and MONDELEZ INTERNATIONAL INC Common Stock pays a 3.43% dividend while Synopsys, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold MONDELEZ INTERNATIONAL INC Common Stock for 107 Days and Synopsys, Inc. for 71 Days on average.
| MDLZ | SNPS | |
|---|---|---|
Market Cap | $77.43B | $95.39B |
Volume | 7,695,104 | 3,374,903 |
Sector | Consumer Staples | Technology |
52-Week High | $64.99 | $534.56 |
52-Week Low | $51.51 | $367.70 |
Typical Hold Time | 107 Days | 71 Days |
Enterprise Value | $97.78B | $102.62B |
Dividend Yield | 3.43% | — |
Signals from Pluang's Aura AI — not financial advice
Mondelez International (MDLZ) trades at $60.41, up 1.73% with a bullish technical signal. The company shows strong fundamentals with consistent earnings beats, $38.54B in 2025 revenue, and improving cash flow. Analyst consensus is strongly bullish with a $70.29 price target. Recent developments include a dividend increase to $0.52 and new product launches like Toblerone Diamond Truffles.
MDLZ presents a compelling investment case with solid profitability (8.86% net margin), attractive valuation (P/E 22.22), and strong analyst support. Key risks include cocoa cost pressures and competitive threats. The stock offers upside potential to consensus targets while providing defensive characteristics in volatile markets.
Synopsys (SNPS) stock trades at $505.76, up 0.61% today, near its 52-week high. The technical picture is bullish with strong moving average support, though RSI levels suggest overbought conditions. Fundamentally, the company reported strong quarterly earnings beats and robust revenue growth, driven by AI partnerships with OpenAI and Amazon. Analyst sentiment is overwhelmingly positive with a 93% buy rating and a consensus price target of $572.54, indicating significant upside potential.
The outlook for SNPS is highly favorable, supported by AI-driven demand for chip design software and strategic acquisitions like Ansys. Key risks include high valuation multiples and integration challenges from recent deals. Investors should focus on execution of growth initiatives and monitor competitive pressures in the semiconductor design software market.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Mondelez has operated as an independent organization since its split from the former Kraft Foods North American grocery business in October 2012. The firm is a leading player in the global snack arena with a presence in the biscuit (47% of sales), chocolate (32%), gum/candy (10%), beverage (4%), and cheese and grocery (7%) aisles. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, Trident, and Cadbury, among others. The firm derives around one third of revenue from developing markets, nearly 40% from Europe, and the remainder from North America.
Read more on MDLZ →Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →